Increased Expression of Hepatocyte Nuclear Factor 6 Stimulates Hepatocyte Proliferation During Mouse Liver Regeneration  Yongjun Tan, Yuichi Yoshida,

Slides:



Advertisements
Similar presentations
Volume 131, Issue 1, Pages (July 2006)
Advertisements

by Kumar Kotlo, Douglas E. Hughes, Victoria L. M
Volume 35, Issue 4, Pages (August 2009)
Volume 132, Issue 5, Pages (May 2007)
Volume 138, Issue 3, Pages e2 (March 2010)
Volume 131, Issue 1, Pages (July 2006)
Volume 11, Issue 6, Pages (June 2003)
A Novel Cofactor for p300 that Regulates the p53 Response
Large Hepatitis Delta Antigen Modulates Transforming Growth Factor-β Signaling Cascades: Implication of Hepatitis Delta Virus–Induced Liver Fibrosis 
Volume 118, Issue 4, Pages (April 2000)
Volume 128, Issue 1, Pages (January 2005)
MafB negatively regulates RANKL-mediated osteoclast differentiation
Volume 55, Issue 1, Pages (July 2014)
Volume 136, Issue 5, Pages (May 2009)
PTF1α/p48 and cell proliferation
Volume 129, Issue 5, Pages (November 2005)
Requirement of heat shock protein 90 in mesangial cell mitogenesis
The homeodomain protein Cdx2 regulates lactase gene promoter activity during enterocyte differentiation  Rixun Fang, Nilda A. Santiago, Lynne C. Olds,
Volume 125, Issue 6, Pages (December 2003)
Histone deacetylase 3 associates with and represses the transcription factor GATA-2 by Yukiyasu Ozawa, Masayuki Towatari, Shinobu Tsuzuki, Fumihiko Hayakawa,
Volume 135, Issue 1, Pages (July 2008)
Volume 124, Issue 7, Pages (June 2003)
Volume 138, Issue 2, Pages (February 2010)
Naoko Kanda, Shinichi Watanabe  Journal of Investigative Dermatology 
Volume 136, Issue 5, Pages (May 2009)
Yu-Hsin Chiu, Jennifer Y. Lee, Lewis C. Cantley  Molecular Cell 
Volume 135, Issue 5, Pages e3 (November 2008)
Volume 132, Issue 4, Pages (April 2007)
The interferon regulatory factor ICSBP/IRF-8 in combination with PU
Volume 128, Issue 5, Pages (May 2005)
Volume 16, Issue 6, Pages (December 2004)
Sp1 Is Required for Glucose-Induced Transcriptional Regulation of Mouse Vesicular Glutamate Transporter 2 Gene  Tao Li, Liqun Bai, Jing Li, Suzu Igarashi,
Tat Competes with CIITA for the Binding to P-TEFb and Blocks the Expression of MHC Class II Genes in HIV Infection  Satoshi Kanazawa, Takashi Okamoto,
Cdk4 promotes adipogenesis through PPARγ activation
Volume 138, Issue 5, Pages e2 (May 2010)
Volume 122, Issue 4, Pages (April 2002)
Yongli Bai, Chun Yang, Kathrin Hu, Chris Elly, Yun-Cai Liu 
Polina Iakova, Samir S Awad, Nikolai A Timchenko  Cell 
Volume 137, Issue 1, Pages (July 2009)
Volume 142, Issue 7, Pages e2 (June 2012)
Ras Induces Mediator Complex Exchange on C/EBPβ
SUMO Promotes HDAC-Mediated Transcriptional Repression
Stimulation of Type I Collagen Transcription in Human Skin Fibroblasts by TGF-β: Involvement of Smad 3  Shu-Jen Chen, Weihua Yuan, Yasuji Mori, Anait.
Volume 134, Issue 1, Pages (January 2008)
Vanessa Brès, Tomonori Yoshida, Loni Pickle, Katherine A. Jones 
Volume 133, Issue 4, Pages (October 2007)
Volume 31, Issue 4, Pages (August 2008)
Volume 92, Issue 4, Pages (February 1998)
Volume 132, Issue 4, Pages (April 2007)
Volume 38, Issue 3, Pages (May 2010)
HDAC5, a Key Component in Temporal Regulation of p53-Mediated Transactivation in Response to Genotoxic Stress  Nirmalya Sen, Rajni Kumari, Manika Indrajit.
A Novel Role of Transforming Growth Factor β1 in Transcriptional Repression of Human Cholesterol 7α-Hydroxylase Gene  Tiangang Li, John Y.L. Chiang  Gastroenterology 
MyoD Targets TAF3/TRF3 to Activate Myogenin Transcription
A Critical Role for Noncoding 5S rRNA in Regulating Mdmx Stability
Volume 142, Issue 4, Pages e4 (April 2012)
Volume 127, Issue 4, Pages (October 2004)
Yi Tang, Jianyuan Luo, Wenzhu Zhang, Wei Gu  Molecular Cell 
Volume 26, Issue 6, Pages (June 2007)
Dan Yu, Rongdiao Liu, Geng Yang, Qiang Zhou  Cell Reports 
Transcriptional Regulation of AKT Activation by E2F
In Vitro Analysis of Huntingtin-Mediated Transcriptional Repression Reveals Multiple Transcription Factor Targets  Weiguo Zhai, Hyunkyung Jeong, Libin.
Volume 14, Issue 2, Pages (April 2004)
Transcriptional Regulation by p53 through Intrinsic DNA/Chromatin Binding and Site- Directed Cofactor Recruitment  Joaquin M Espinosa, Beverly M Emerson 
Volume 4, Issue 4, Pages (October 1999)
Mary O'Riordan, Rudolf Grosschedl  Immunity 
PU.1 Expression Delineates Heterogeneity in Primary Th2 Cells
Volume 55, Issue 1, Pages (July 2014)
A Smad Transcriptional Corepressor
Volume 112, Issue 6, Pages (March 2003)
Acetylation Regulates Transcription Factor Activity at Multiple Levels
Presentation transcript:

Increased Expression of Hepatocyte Nuclear Factor 6 Stimulates Hepatocyte Proliferation During Mouse Liver Regeneration  Yongjun Tan, Yuichi Yoshida, Douglas E. Hughes, Robert H. Costa  Gastroenterology  Volume 130, Issue 4, Pages 1283-1300 (April 2006) DOI: 10.1053/j.gastro.2006.01.010 Copyright © 2006 American Gastroenterological Association Institute Terms and Conditions

Figure 1 Adenovirus-mediated increase in hepatic HNF6 expression following partial hepatectomy. Two-month-old CD-1 mice were subjected to tail vein injections of either AdLacZ or AdHNF6. Two days after injection, mice were subjected to partial hepatectomy and remnant-regenerating livers were harvested at indicated time points following partial hepatectomy. At least 3 regenerating mouse livers were used for each time point. (A) AdHNF6-infected regenerating liver displayed increased levels of HNF6 mRNA. RPAs were performed to detect mouse HNF6 expression in either AdLacZ-infected or AdHNF6-infected livers at the indicated time points following partial hepatectomy, and cyclophilin levels were used as a loading control. (B–I) AdHNF6 infection increases nuclear levels of HNF6 protein in regenerating hepatocytes. We used affinity-purified HNF6 antibody for immunohistochemical staining of liver sections at the indicated hours following partial hepatectomy from mice infected with either (B, D, F, and H) AdLacZ or (C, E, G, and I) AdHNF6. (Original magnification 200×.) Gastroenterology 2006 130, 1283-1300DOI: (10.1053/j.gastro.2006.01.010) Copyright © 2006 American Gastroenterological Association Institute Terms and Conditions

Figure 2 Adenovirus-mediated increase in hepatic HNF6 expression stimulates levels of hepatocyte DNA replication and mitosis following partial hepatectomy. Adenovirus infections and partial hepatectomy were performed as described in the legend to Figure 1 and in Materials and Methods. (A) Graph depicting increased hepatocyte DNA replication in AdHNF6-infected mice following partial hepatectomy. Mice undergoing liver regeneration were injected with BrdU 2 hours before they were killed. DNA replication was determined from the number of hepatocytes that incorporated BrdU measured by immunohistochemical staining of regenerating liver sections with BrdU antibody. DNA replication was determined by counting the number of BrdU-stained hepatocytes from 1000 cells using 3 regenerating mouse livers per time point after partial hepatectomy. Graphic representation of the mean number of the BrdU-positive hepatocytes per 1000 cells (±SD) from mice undergoing liver regeneration infected with either AdLacZ (circles) or AdHNF6 (squares, thick line) was plotted against the hours following partial hepatectomy. Also shown is immunohistochemical staining of liver sections at 40 hours following partial hepatectomy with BrdU antibody from mice infected with either (B) AdLacZ or (C) AdHNF6. (D) Increased hepatocyte mitosis in AdHNF6-infected mice following partial hepatectomy. Regenerating liver sections were stained with H&E and used to detect mitotic figures (mitosis) between 36 and 48 hours following partial hepatectomy, and we used 3 regenerating mouse livers per time point to determine hepatocyte mitosis as described above for BrdU incorporation rate. Graphic representation of the mean number of mitotic figures per 1000 hepatocytes (±SD) from mice undergoing liver regeneration infected with either AdLacZ (white bar) or AdHNF6 (black bar) was plotted against the hours following partial hepatectomy. The asterisks indicate statistically significant changes: *P ≤ .05 and **P ≤ .01. Gastroenterology 2006 130, 1283-1300DOI: (10.1053/j.gastro.2006.01.010) Copyright © 2006 American Gastroenterological Association Institute Terms and Conditions

Figure 3 Increased expression of cyclin D1, Foxm1, TGF-α, and Cdk2 during liver regeneration in AdHNF6-infected mice. (A and B) Increased hepatic mRNA levels of Foxm1 transcription factor, cyclin D1, and TGF-α in regenerating livers from AdHNF6-infected mice. Total RNA was isolated from regenerating liver of mice that were infected with either AdLacZ or AdHNF6 and analyzed for mRNA expression by RPAs (in triplicate) with probes specific to either (B) HNF6, (B) TGF-α, (A) Foxm1, or (A) cyclin D1. Note that representative duplicate samples are shown and that cyclophilin or large subunit 32 levels were used to normalize expression levels. Mean mRNA expression levels of 2-month-old CD-1 mouse liver at either (A) 0 hours or (B) 32 hours after partial hepatectomy were set at 1.0. (C) Increased protein levels of cyclin D1 and Cdk2 during regenerating livers in AdHNF6-infected mice. Total protein extracts were isolated from regenerating liver and analyzed for Cdk2 and cyclin D1 expression by Western blot analysis. Note that representative duplicate samples from 2 distinct regenerating mouse livers are shown and that β-actin protein band was used to normalize expression levels. Quiescent mock-infected liver (MI) was set at 1.0. The asterisk indicates statistically significant changes: *P ≤ .05. Gastroenterology 2006 130, 1283-1300DOI: (10.1053/j.gastro.2006.01.010) Copyright © 2006 American Gastroenterological Association Institute Terms and Conditions

Figure 4 HNF6 and FoxM1 proteins activate transcription of the cyclin D1 and TGF-α promoter regions in cotransfection assays. (A) AdHNF6 infection of HepG2 cells increases mRNA expression of endogenous human TGF-α gene. HepG2 cells were either mock infected (MI) or infected with AdLacZ (LacZ) or AdHNF6 (H6); 24 hours after infection, RNA was isolated and analyzed for mRNA expression by RPAs with probes specific to either HNF6 or TGF-α. (B and C) CMV-HNF6 and CMV-FoxM1b expression vectors activate transcription of the cyclin D1 and TGF-α promoter regions in cotransfection assays. HepG2 cells were transfected with the (B) −1.7-kb mouse TGF-α promoter or the (C) −1.7-kb human cyclin D1 promoter luciferase plasmid and either CMV HNF-6 cDNA (HNF6) or CMV empty expression vectors. At 24 hours after transfection, the cells were used to prepare cell extracts, which were then analyzed for dual luciferase enzyme activity as described in Materials and Methods. We also examined whether cotransfection of these promoters with the CMV human FoxM1b expression vector (FoxM1b) could stimulate expression of these promoter regions and synergize with the HNF6 transcription factor (HNF6 + FoxM1b). Results are presented as mean fold induction of promoter activity (±SD) from 2 separate experiments in triplicate, with the CMV empty value set at 1.0. The asterisks indicate statistically significant changes: *P ≤ .05 and **P ≤ .01.. Gastroenterology 2006 130, 1283-1300DOI: (10.1053/j.gastro.2006.01.010) Copyright © 2006 American Gastroenterological Association Institute Terms and Conditions

Figure 5 ChIP assay shows that HNF6 and FoxM1 proteins bind to the endogenous TGF-α and cyclin D1 promoter regions. The mouse TGF-α promoter region contains distinct DNA binding sequences for the HNF6 protein (−1608 to −1591 bp) and the FoxM1 protein (−1561 to −1531 bp), whereas these transcription factors bind to the same DNA sequence in the mouse cyclin D1 promoter region (−1064 to −1049 bp). Mouse hepatoma Hepa1-6 cells were mock infected or infected with AdHNF6 or AdGFP. For the cyclin D1 promoter ChIP assays (D), we also infected Hepa1-6 cells with AdHNF6 or adenovirus-expressing human FoxM1b separately or together. At 24 hours after infection, the chromatin was cross-linked, sonicated to DNA fragments of 500–1000 nucleotides in length, and then processed for ChIP assays as described in Materials and Methods. The cross-linked and sonicated mouse chromatin was immunoprecipitated with antibodies specific to either HNF6 (+, A and B) or FoxM1 (+, C and D) or with rabbit antisera (−), and the amount of promoter DNA associated with the immunoprecipitated chromatin was quantitated by real-time PCR with primers specific to either (A and C) the −1647 to −1495 bp mouse TGF-α promoter region or (B and D) the −890 to −733 bp mouse cyclin D1 promoter region. The asterisks indicate statistically significant changes: *P ≤ .05, **P ≤ .01, and ***P ≤ .001. Gastroenterology 2006 130, 1283-1300DOI: (10.1053/j.gastro.2006.01.010) Copyright © 2006 American Gastroenterological Association Institute Terms and Conditions

Figure 6 Association of the HNF6 and FoxM1 proteins results in stimulation of Foxm1 transcriptional activity. (A) Coimmunoprecipitation assays with regenerating liver extracts show a functional association between the HNF6 and Foxm1 transcription factors. We performed coimmunoprecipitation assays with protein extracts from quiescent mouse liver (0h) that lack detectable expression of FoxM1 protein or regenerating mouse liver isolated at 40 hours following partial hepatectomy (40h), which express abundant levels of FoxM1 protein (Foxm1 Input). Quiescent or regenerating mouse liver extracts were coimmunoprecipitated with the HNF6 antibody, and then immunoprecipitated proteins were subjected to Western blot analysis with the FoxM1 C-terminal antibody. (B) In vitro GST pull-down assays showed that HNF6 cut-homeodomain protein interacts with the FoxM1b winged helix domain. The right panel shows the expression levels of the GST, GST-FoxM1b N-terminal (N; amino acids 1–138), or GST-FoxM1b binding domain (DBD; amino acids 221–355) fusion proteins separated by SDS-PAGE and stained with Coomassie blue. The HNF6 cut-homeodomain DBD plasmid was used to synthesize radioactively labeled HNF6 DBD protein using in vitro transcription and translation with 35S-methionine and used for the in vitro GST-FoxM1b pull-down assays, and bound labeled HNF6 protein was separated by SDS-PAGE and visualized by autoradiography (left panel). (C and D) Cotransfection studies show that HNF6 stimulates the ability of FoxM1b to activate Foxm1-dependent target promoters. (C) Human hepatoma HepG2 or (D) osteosarcoma U2OS cells were cotransfected with the Foxm1 reporter gene 6X Foxm1 TATA luciferase reporter gene53 and increasing amounts of CMV HNF6 expression vector and constant amount of CMV FoxM1b expression vectors (numbers represent nanograms transfected). Cotransfection of CMV-HNF6 expression vector could not stimulate expression of the FoxM1 reporter gene in either HepG2 or U2OS cells. (E) Cotransfection assays showed that HNF6 also stimulated the ability of FoxM1b to stimulate transcription of the −2.7-kb Cdc25B promoter region, which is a known transcriptional target of Foxm1.23 The asterisks indicate statistically significant changes: *P ≤ .05 and **P ≤ .01. Gastroenterology 2006 130, 1283-1300DOI: (10.1053/j.gastro.2006.01.010) Copyright © 2006 American Gastroenterological Association Institute Terms and Conditions

Figure 7 HNF6 and Foxm1 regulate transcription of the HNF6 promoter as determined by cotransfection and ChIP assays. (A) Infection of HepG2 cells with AdHNF6 stimulated expression of the endogenous human HNF6 gene. HepG2 cells were infected with AdHNF6, and RNA was isolated at different times after AdHNF6 infection and analyzed for HNF6 expression by RPAs. (B) HNF6 protein binds to its own promoter region. Electrophoretic mobility shift assays with AdHNF6-infected HepG2 cell extracts and radioactively labeled double-stranded oligonucleotide synthesized to the −1368 to −1329 bp human HNF6 promoter region form a specific HNF6 protein-DNA complex that was inhibited by including in the binding reaction either a 100-fold excess of cold homologous oligonucleotide or HNF6 antisera. (C) HepG2 cell cotransfection assays show that HNF6 and FoxM1b stimulates transcription of the −1.4-kb human HNF6 promoter region. HepG2 cells were cotransfected with either −1.4-kb or −1.3-kb human HNF6 promoter luciferase plasmid and CMV-HNF6 and CMV-FoxM1b expression vectors either alone or together. At 24 hours after transfection, the cells were used to prepare cell extracts, which were then analyzed for dual luciferase enzyme activity as described in Materials and Methods. (D and E) Quantitative ChIP assays revealed that Foxm1 and HNF6 proteins bind to the endogenous human HNF6 promoter region. HepG2 cells were mock infected or infected with either AdHNF6 or AdGFP, and 24 hours after infection the chromatin was cross-linked and processed for ChIP assays as described in Materials and Methods. The cross-linked and sonicated mouse chromatin was immunoprecipitated with antibodies specific to either HNF6 (+, D) or FoxM1 (+, E) or with rabbit antisera (−), and the amount of promoter DNA associated with the immunoprecipitated chromatin was quantitated by real-time PCR with primers specific to −1499 to −1337 bp of the human HNF6 promoter region. The asterisks indicate statistically significant changes: *P ≤ .05, **P ≤ .01, and ***P ≤ .001. Gastroenterology 2006 130, 1283-1300DOI: (10.1053/j.gastro.2006.01.010) Copyright © 2006 American Gastroenterological Association Institute Terms and Conditions

Figure 8 Diminished HNF6 levels in Hepa1-6 cells by siRNA transfection cause a significant decrease in DNA replication following serum stimulation. Mouse hepatoma Hepa1-6 cells were transfected with HNF6 siRNA or control siRNA or left untransfected, serum starved for 48 hours, and then stimulated to reenter the cell cycle with the addition of 10% fetal calf serum. These siRNA-transfected or untreated Hepa1-6 cells were subjected to a 1-hour pulse label with BrdU before harvesting them at 16 hours after serum stimulation, and then DNA replication was determined by immunostaining of cells with BrdU antibody. (A and B) RPAs and Western blot analysis showed that transfection of Hepa1-6 cells with HNF6 siRNA caused a 50% reduction in levels of HNF6 mRNA and protein, but HNF6 expression was not influenced by transfection with a control siRNA. (C) Graph depicting a reduced number of BrdU-positive Hepa1-6 cells depleted in HNF6 levels following serum stimulation. Diminished number of BrdU-positive Hepa1-6 cells after transfection of HNF6 siRNA to diminish HNF6 expression compared with Hepa1-6 cells transfected with control siRNA or left untransfected. Quantitation of the BrdU incorporation rates by counting the number of BrdU-positive Hepa1-6 cells in 5 fields from 3 different HNF6 siRNA-transfected cell plates. Student t test determines statistically significant decrease in BrdU incorporation. The asterisks indicate statistically significant changes: **P ≤ .01 and ***P ≤ .001. Gastroenterology 2006 130, 1283-1300DOI: (10.1053/j.gastro.2006.01.010) Copyright © 2006 American Gastroenterological Association Institute Terms and Conditions